Stacy Ku News Today : Breaking News, Live Updates & Top Stories | Vimarsana

scPharmaceuticals Inc (NASDAQ:SCPH) Q1 2024 Earnings Call Transcript

scPharmaceuticals Inc (NASDAQ:SCPH) Q1 2024 Earnings Call Transcript
insidermonkey.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from insidermonkey.com Daily Mail and Mail on Sunday newspapers.

United statesSan diegoGlen santangeloStacy kuRoanna ruizJohn tuckerSteve parsonsDouglas tsaoNaz rahmanRachael nokesUniversity of californiaYork heart association classNaz rahman at maxim groupPharmaceuticals first quarterPharmaceuticals incScpharmaceuticals inc

Verrica Pharmaceuticals Inc (NASDAQ:VRCA) Q1 2024 Earnings Call Transcript

Verrica Pharmaceuticals Inc (NASDAQ:VRCA) Q1 2024 Earnings Call Transcript
insidermonkey.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from insidermonkey.com Daily Mail and Mail on Sunday newspapers.

New yorkUnited statesGary goldenbergStacy kuKemp dolliverAnish nikhanjGlen santangeloTed whiteJoe bonaccorsoGregory renzaUnitedhealthcare optumChris calabreseSerge belangerChris hayesOren livnatTerry kohler

Revance Therapeutics, Inc (NASDAQ:RVNC) Q1 2024 Earnings Call Transcript

Revance Therapeutics, Inc (NASDAQ:RVNC) Q1 2024 Earnings Call Transcript
insidermonkey.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from insidermonkey.com Daily Mail and Mail on Sunday newspapers.

Mark foleyChris shibutaniAnnabel samimyTobin schilkeSeamus fernandezStacy kuToby schilkeRevance therapeutics incGoldman sachsRevance therapeuticsCall transcript mayRevance therapeutics first quarterCorporate update conferenceLaurence wattsNew street investorWatts thank

BioCryst Pharmaceuticals (BCRX) Q1 2024 Earnings Call Transcript

BCRX earnings call for the period ending March 31, 2024.

United statesAnthony doyleHelen thackrayTazeen ahmadMaury raycroft jefferiesGena wang barclaysFrancois briseboisJon stonehouseCharlie gayerBrian abrams abrahamsAmerica merrill lynchChris raymond piper sandlerLiisa bayko evercoreJessica fyeLiisa baykoJon wolleben

Aurinia Pharmaceuticals Inc (NASDAQ:AUPH) Q1 2024 Earnings Call Transcript

Aurinia Pharmaceuticals Inc. beats earnings expectations. Reported EPS is $-0.07464, expectations were $-0.17.

United statesFarzin haqueGreg keenanStacy kuAndrea christopherJoe millerPeter greenleafMaury raycroftInvestor relations for aurinia pharmaceuticalsExchange commissionAurinia pharmaceuticals first quarterHead of corporate communicationsAurinia pharmaceuticals incAurinia pharmaceuticalsCall transcript mayCorporate communications